Skip to main content

Table 3 PK parameters of nicotine in plasma at steady state after 12 hourly doses of 1 mg lozenge or 2 mg gum (mean ± SD; n = 24)

From: Pharmacokinetics, safety and efficacy from randomized controlled trials of 1 and 2 mg nicotine bitartrate lozenges (Nicotinell®)

Formulation\PK parameter

Nicotinell® lozenge

Nicorette® gum

90% CI (lozenge/gum)#

 

1 mg

2 mg

 

C max (ng/ml)

10.6 ± 2.9

11.4 ± 3.8

0.86–1.04

C min (ng/ml)

8.1 ± 2.4

9.3 ± 3.4

ND

t max (h) [range]

0.54 ± 0.21 [0.00–0.77]

0.47 ± 0.19 [0.20–0.95]

ND

t 1/2 (h)

3.6 ± 1.2

3.2 ± 0.9

ND

AUC 11–12 (h·ng/ml)

9.2 ± 2.6

10.2 ± 3.4

0.84–1.01

  1. Initial nicotine concentrations in plasma were 1.1 ng/ml (range: 0.0–6.5) with lozenge and 0.9 ng/ml (0.0–5.1) with gum, reflecting volunteers' heavy smoking habits (≥ 20 cigarettes per day). Correction for initial nicotine concentrations did not modify the results and thus was not retained. ND: not determined.
  2. †: PK parameters were determined from blood samples drawn after dose 12 (t = 11 h) until t = 23 h.
  3. ‡: a dose adjustment of the raw data was done for a last standard dose of 1 mg nicotine delivery from the gum.
  4. #: Standard 90% CI for the expected mean ratio was derived from ANOVA for continuous parameters and compared to standard BAR [0.80–1.25].